AstraZeneca boss Pascal Soriot’s pay rises to £17.7m

The Guardian - World NewsEN 2 min read 100% complete by Julia KolleweFebruary 24, 2026 at 03:01 PM
AstraZeneca boss Pascal Soriot’s pay rises to £17.7m

AI Summary

medium article 2 min

AstraZeneca CEO Pascal Soriot's total compensation rose 6.4% to £17.7m in the past year, driven by a £1.5m salary, £4.3m in bonuses, and £11.6m in share bonuses, reflecting a 32% increase in AstraZeneca's share price and strong financial performance. Despite this, AstraZeneca cancelled a £450m expansion of its vaccine site in Speke and halted a £200m research investment in Cambridge due to a dispute with the government over drug pricing. Soriot is in line for a further pay increase this year, potentially reaching £19.6m. His high pay has previously triggered shareholder rebellions, despite the company's improved financial performance. Since joining AstraZeneca in 2012, Soriot has rebuilt the company's drug pipeline and fended off a takeover bid from Pfizer.

Keywords

executive compensation 90% pascal soriot 80% astrazeneca 80% pay rise 70% pharmaceutical company 60% share price 50% annual bonuses 50% drug pricing 40% financial performance 40%

Sentiment Analysis

Negative
Score: -0.20

Source Transparency

Source
The Guardian - World News
Classification Confidence
90%
Geographic Perspective
United Kingdom

This article was automatically classified using rule-based analysis.

Topic Connections

Explore how the topics in this article connect to other news stories

No topic relationship data available yet. This graph will appear once topic relationships have been computed.
Explore Full Topic Graph

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.